Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms
- PMID: 32333725
- DOI: 10.1002/cyto.b.21881
Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms
Abstract
Background: Flow cytometric detection of T-cell clonality is challenging. The current available methodology for T-cell receptor (TCR) Vβ repertoire evaluation is a complex assay and has limited sensitivity especially for detecting low levels of disease. Therefore, there is an unmet need for a reliable, simple, and rapid assay to identify T-cell clonality. The rearrangement of the TCRB gene involves the random and mutually exclusive expression of one of two constant β chain genes (TRBC1 and TRBC2), analogous to the kappa and lambda gene utilization by B cells.
Methods: Here, we used a single TRBC1 antibody, in conjunction with other T-cell associated markers, to detect T-cell clonality in tissue biopsies and body fluids. A total of 143 tissue/body fluid specimens from 46 patients with a definitive diagnosis of a T-cell neoplasm and 97 patients with no T-cell malignancy were analyzed with a cocktail of monoclonal antibodies including CD2/CD3/CD4/CD5/CD7/CD8/CD45/TCRγδ/TRBC1.
Results: We examined TRBC1 expression on neoplastic T-cell populations identified based on their immunophenotypic aberrancies, and monotypic TRBC1 expression was identified in all 46 known T-cell lymphoma cases. We applied a similar gating strategy to the 97 cases without T-cell neoplasms, and arbitrarily dissected T-cell populations into immunophenotypically distinct subsets; in this group, we found that all cases revealed an expected polytypic TRBC1 expression in all subsets.
Conclusions: Single TRBC1 antibody detection of T-cell clonality by flow cytometry is a simple, rapid, and robust assay that could be routinely utilized in flow cytometric laboratories.
Keywords: T-cell clonality; T-cell neoplasms; TRBC1; flow cytometry.
© 2020 International Clinical Cytometry Society.
References
REFERENCES
-
- Aggarwal, N., Fischer, J., Swerdlow, S. H., & Craig, F. E. (2013). Splenic lymphoid subsets with less well-recognized phenotypes mimic aberrant antigen expression. American Journal of Clinical Pathology, 140, 787-794.
-
- Andreu-Ballester, J. C., Garcia-Ballesteros, C., Benet-Campos, C., Amigo, V., Almela-Quilis, A., Mayans, J., & Ballester, F. (2012). Values for alphabeta and gammadelta T-lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: Assessment by age and gender. Cytometry Part B, Clinical Cytometry, 82, 238-244.
-
- Bruggemann, M., White, H., Gaulard, P., Garcia-Sanz, R., Gameiro, P., Oeschger, S., … Molina, T. J. (2007). Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies report of the BIOMED-2 concerted action BHM4 CT98-3936. Leukemia, 21, 215-221.
-
- Chen, W., Kesler, M. V., Karandikar, N. J., McKenna, R. W., & Kroft, S. H. (2006). Flow cytometric features of angioimmunoblastic T-cell lymphoma. Cytometry Part B, Clinical Cytometry, 70, 142-148.
-
- Jamal, S., Picker, L. J., Aquino, D. B., McKenna, R. W., Dawson, D. B., & Kroft, S. H. (2001). Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. American Journal of Clinical Pathology, 116, 512-526.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
